Streetbeat News

Revenues

EADSY

Airbus SE is facing supply chain challenges that could delay jet deliveries, potentially impacting its 2024 delivery targets. Boeing Co is also experiencing similar issues. Airbus shares are down 1.24%, while Boeing shares are up 0.63%.

Portfolio Pulse from Akanksha Bakshi

May 31, 2024 | 2:31 pm

PSA

Public Storage (NYSE:PSA) has outperformed the market over the past 20 years with an average annual return of 9.08%, resulting in a $1000 investment growing to $5,708.38. The company currently has a market capitalization of $47.54 billion.

Portfolio Pulse from Benzinga Insights

May 31, 2024 | 2:30 pm

APH

Amphenol (NYSE:APH) has significantly outperformed the market over the past 5 years, delivering an average annual return of 24.02%. A $1000 investment in APH 5 years ago would now be worth $3,015.84. The company's current market capitalization is $79.47 billion.

Portfolio Pulse from Benzinga Insights

May 31, 2024 | 2:30 pm

BIIB

IONS

The European Commission has granted marketing authorization for Biogen's Qalsody (tofersen) for treating amyotrophic lateral sclerosis (ALS) associated with a mutation in the SOD1 gene. This is the first treatment in the EU targeting a genetic cause of ALS. Despite the Phase 3 VALOR study showing numerical but not statistically significant efficacy, Qalsody has shown a significant reduction in neurofilament light chain levels. Biogen licensed Qalsody from Ionis Pharmaceuticals.

Portfolio Pulse from Vandana Singh

May 31, 2024 | 2:25 pm

NFLX

Netflix's stock rose by 2% on Wednesday due to positive forecasts from industry analysts predicting a 30% rise. The company is expected to gain over 30 million new subscribers and achieve double-digit revenue growth, driven by its expanding advertising ventures and strategic moves into gaming, live event streaming, and sports broadcasting. Analysts have raised their price targets for Netflix, reflecting its strong market position and financial health.

Portfolio Pulse from Zaheer Anwari

May 31, 2024 | 2:19 pm

AMD

MSFT

NVDA

Zhipu AI, a Chinese AI company backed by Microsoft, has secured a $400 million investment from Saudi Arabia's Prosperity7, part of Aramco's venture capital arm. This investment values Zhipu AI at $3 billion and marks a significant foreign backing amid U.S. restrictions on AI investments in China. The geopolitical implications are notable, with the U.S. halting AI chip exports to the Middle East, affecting companies like Nvidia and AMD.

Portfolio Pulse from Anusuya Lahiri

May 31, 2024 | 2:11 pm

CRM

MSFT

Salesforce Inc (NYSE:CRM) reported its first quarterly revenue miss since 2006 and provided softer-than-expected guidance. Despite this, analysts remain optimistic about Salesforce's potential in the AI space. The company reported an 11% revenue growth to $9.13 billion, missing the consensus estimate of $9.17 billion. Net income grew significantly to $1.53 billion. Salesforce's second-quarter guidance fell short of expectations, but it raised its fiscal 2025 adjusted earnings guidance. Analysts believe Salesforce will benefit from generative AI, although competition from Microsoft and others remains a concern.

Portfolio Pulse from Upwallstreet

May 31, 2024 | 2:10 pm

BTCUSD

DELL

ETHUSD

The article covers a range of topics including Ethereum facing major attacks and dominating May's cryptocurrency losses, Bitcoin spot ETFs seeing significant inflows, and various market and political updates. Key highlights include Ethereum's potential to hit $10K by year-end, Ripple CEO's predictions on crypto ETFs, and significant movements in tech stocks like Dell and Zscaler.

Portfolio Pulse from Akanksha Bakshi

May 31, 2024 | 2:07 pm

CLDI

LUCY

NVOS

SIFY

SMFL

XHG

US stocks traded mostly higher on Friday, with the Dow Jones gaining around 75 points. The headline PCE inflation rate held steady at 2.7% year-on-year in April, matching economist expectations. Notable stock movements included significant gains for Novo Integrated Sciences, XChange Tec, and Innovative Eyewear, while Sify Technologies, Smart for Life, and Calidi Biotherapeutics saw substantial declines.

Portfolio Pulse from Avi Kapoor

May 31, 2024 | 2:03 pm

VALN

Analysts have provided mixed ratings for Valneva (NASDAQ:VALN) over the past three months, with a total of 6 bullish ratings. The average 12-month price target has increased to $24.5, reflecting a 5.02% rise from the previous target. Valneva's financial health shows strong profitability and efficient asset utilization, but it faces revenue growth challenges and high debt levels.

Portfolio Pulse from Benzinga Insights

May 31, 2024 | 2:01 pm